Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Profit After Tax

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Profit After Tax History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit After Tax ₹1,047 Cr₹-1,831 Cr₹-90 Cr₹994 Cr₹970 Cr

What is the latest Profit After Tax of GLENMARK PHARMACEUTICALS ?

The latest Profit After Tax ratio of GLENMARK PHARMACEUTICALS is ₹1,047 Cr based on Mar2026 Consolidated results.
Year Profit After Tax
Mar2026₹1,047 Cr
Mar2025₹-1,831 Cr
Mar2024₹-90 Cr
Mar2023₹994 Cr
Mar2022₹970 Cr

How is Profit After Tax of GLENMARK PHARMACEUTICALS Trending?

Years Profit After Tax % Change
Mar2026 ₹1,047 Cr
Positive
Mar2025 ₹-1,831 Cr
Negative
Mar2024 ₹-90 Cr
Negative
Mar2023 ₹994 Cr
2.43
Mar2022 ₹970 Cr -

Compare Profit After Tax of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹67,248.3 Cr -2.7% -2.3% 17.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.7%

-2.3%

17.1%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses